| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Dec 1, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -2,944 | -0.03% | ✗ | $88.8K |
| Nov 23, 2025 | Nov 25, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -2,116 | -0.02% | ✗ | $63.5K |
| Aug 26, 2025 | Aug 28, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -2,944 | -0.03% | ✗ | $63.2K |
| Aug 23, 2025 | Aug 26, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -2,115 | -0.02% | ✗ | $46K |
| Aug 1, 2025 | Aug 5, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,339 | -0.01% | ✗ | $24.8K |
| May 23, 2025 | May 28, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -5,060 | -0.06% | ✗ | $102.8K |
| May 1, 2025 | May 5, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,339 | -0.01% | ✗ | $23.1K |
| Feb 25, 2025 | Feb 27, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 85.0 | +117,163 | 1.33% | ✗ | $770.8K |
| Feb 23, 2025 | Feb 25, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -2,324 | -0.03% | ✗ | $38.3K |
| Feb 1, 2025 | Feb 4, 2025 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,472 | -0.02% | ✗ | $24.5K |
| Nov 25, 2024 | Nov 27, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -2,227 | -0.03% | ✗ | $40.7K |
| Nov 1, 2024 | Nov 5, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,337 | -0.02% | ✗ | $28.9K |
| Aug 27, 2024 | Aug 29, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -2,313 | -0.03% | ✗ | $52.8K |
| Aug 1, 2024 | Aug 5, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,337 | -0.02% | ✗ | $31.5K |
| May 23, 2024 | May 28, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -2,111 | -0.02% | ✗ | $44.6K |
| May 1, 2024 | May 3, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,337 | -0.02% | ✗ | $27.7K |
| Feb 26, 2024 | Feb 28, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 75.0 | +81,671 | 0.93% | ✗ | $437.9K |
| Feb 23, 2024 | Feb 27, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -8,667 | -0.10% | ✗ | $208.5K |
| Feb 1, 2024 | Feb 5, 2024 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,094 | -0.01% | ✗ | $27.3K |
| Nov 1, 2023 | Nov 3, 2023 | Fulgent Genetics, Inc. | CEO | Sell | 51.3 | -1,309 | -0.01% | ✗ | $31.1K |
| Aug 1, 2023 | Aug 3, 2023 | Fulgent Genetics, Inc. | CEO | Sell | 47.5 | -4,783 | -0.05% | ✗ | $185.7K |
| Feb 23, 2023 | Feb 27, 2023 | Fulgent Genetics, Inc. | CEO | Sell | 72.5 | +52,384 | 0.60% | ✗ | $83.1K |
| Mar 5, 2019 | Mar 7, 2019 | Fulgent Genetics, Inc. | CEO | Buy | 56.3 | +8,739 | 0.11% | ✗ | $43.2K |
| Nov 13, 2018 | Nov 15, 2018 | Fulgent Genetics, Inc. | CEO | Buy | 56.3 | +10,880 | 0.14% | ✗ | $39K |
| Nov 9, 2018 | Nov 13, 2018 | Fulgent Genetics, Inc. | CEO | Buy | 56.3 | +10,000 | 0.13% | ✗ | $33.6K |
| Sep 7, 2018 | Sep 10, 2018 | Fortinet, Inc. | Director | Sell | 20.0 | -7,015 | -100.00% | ✗ | $599.8K |
| Nov 30, 2017 | Dec 4, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 47.5 | +2,000 | 0.03% | ✗ | $7.2K |
| Nov 21, 2017 | Nov 22, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 47.5 | +1,599 | 0.02% | ✗ | $5K |
| Nov 17, 2017 | Nov 21, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 65.0 | +19,550 | 0.25% | ✗ | $62.7K |
| Nov 20, 2017 | Nov 20, 2017 | Fortinet, Inc. | Director | Sell | 26.3 | -331 | -100.00% | ✗ | $13.4K |
| Nov 15, 2017 | Nov 17, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 47.5 | +2,205 | 0.03% | ✗ | $7.1K |
| Nov 13, 2017 | Nov 15, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 56.3 | +10,504 | 0.13% | ✗ | $34.6K |
| Nov 9, 2017 | Nov 13, 2017 | Fortinet, Inc. | Director | Sell | 22.5 | -5,332 | -94.16% | ✗ | $211.4K |
| Nov 9, 2017 | Nov 13, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 65.0 | +20,905 | 0.27% | ✗ | $71.4K |
| Jun 14, 2017 | Jun 15, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 65.0 | +20,000 | 0.26% | ✗ | $105.2K |
| Jun 12, 2017 | Jun 13, 2017 | Fulgent Genetics, Inc. | CEO | Buy | 65.0 | +30,000 | 0.39% | ✗ | $149.4K |
| Jun 8, 2017 | Jun 9, 2017 | Fortinet, Inc. | Director | Sell | 22.5 | -4,743 | -100.00% | ✗ | $186.4K |
| May 13, 2016 | Oct 4, 2016 | Fulgent Genetics, Inc. | CEO | Buy | 100.0 | +7,760,734 | 142.53% | ✗ | $9M |